Clinical Trial Update: Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

View source ↗

Summary

Completed feasibility study investigating acute dietary changes after GLP-1 receptor agonist treatment in obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist therapy (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: Australian Catholic University | Conditions: Obesity, Type 2 Diabetes Mellitus (T2DM) | Status: COMPLETED